Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-28 @ 8:30 AM
Study NCT ID:
NCT05947669
Status:
RECRUITING
Last Update Posted:
2023-08-24
First Post:
2023-06-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Infliximab for Immune Checkpoint Inhibitor Induced Colitis
Sponsor:
Odense University Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-22
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-14
First Submit QC Date:
None
Study First Post Date:
2023-07-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-22
Last Update Post Date:
2023-08-24
Last Update Post Date Type:
ACTUAL